Aleksandra Kovacevic
Overview
Explore the profile of Aleksandra Kovacevic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rahbe E, Kovacevic A, Opatowski L, Leclerc Q
Wellcome Open Res
. 2024 Oct;
9:248.
PMID: 39372841
Background: Efforts to estimate the global burden of antimicrobial resistance (AMR) have highlighted gaps in existing surveillance systems. Data gathered from hospital networks globally by pharmaceutical industries to monitor antibiotic...
2.
Patic A, Kovacevic G, Vukovic V, Hrnjakovic Cvjetkovic I, Ristic M, Milosavljevic B, et al.
Microorganisms
. 2024 Sep;
12(9).
PMID: 39338474
The currently dominant SARS-CoV-2 omicron variant, while causing mild respiratory symptoms, exhibits high transmissibility, drug resistance, and immune evasion. We investigated whether the presence of the SARS-CoV-2 affected the dynamics...
3.
Kovacevic A, Smith D, Rahbe E, Novelli S, Henriot P, Varon E, et al.
Elife
. 2024 Mar;
13.
PMID: 38451256
Non-pharmaceutical interventions implemented to block SARS-CoV-2 transmission in early 2020 led to global reductions in the incidence of invasive pneumococcal disease (IPD). By contrast, most European countries reported an increase...
4.
Wong A, Barrero Guevara L, Goult E, Briga M, Kramer S, Kovacevic A, et al.
PLoS Pathog
. 2023 Mar;
19(3):e1011167.
PMID: 36888684
Despite the availability of effective vaccines, the persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suggests that cocirculation with other pathogens and resulting multiepidemics (of, for example, COVID-19 and...
5.
Knezevic S, Ostojic J, Ognjanovic M, Savic S, Kovacevic A, Manojlovic D, et al.
Sci Total Environ
. 2022 Oct;
857(Pt 1):159250.
PMID: 36208761
Triclosan (TCS) is a polychlorinated phenoxy phenol (PCPPs) used as a disinfectant and a broad-spectrum antibacterial and antifungal agent in personal hygiene products. TCS easily forms diphenyl ethers and dioxins,...
6.
Miljkovic M, Rancic N, Kovacevic A, Cikota-Aleksic B, Skadric I, Jacevic V, et al.
Front Pharmacol
. 2022 Jul;
13:796336.
PMID: 35784683
Itraconazole is a triazole antifungal agent with highly variable pharmacokinetics, with not yet fully identified factors as the source of this variability. Our study aimed to examine the influence of...
7.
Bernardo A, Lee P, Marcotte M, Mian M, Rezvanian S, Sharmin D, et al.
Neuropsychopharmacology
. 2022 Jun;
47(9):1608-1619.
PMID: 35701547
Chronic stress is a risk factor for Major Depressive Disorder (MDD), and in rodents, it recapitulates human behavioral, cellular and molecular changes. In MDD and after chronic stress, neuronal dysfunctions...
8.
Bennati S, Kovacevic A
Sci Rep
. 2022 Jan;
12(1):246.
PMID: 34996962
Mobility patterns of vehicles and people provide powerful data sources for location-based services such as fleet optimization and traffic flow analysis. Location-based service providers must balance the value they extract...
9.
Kovacevic A, Eggo R, Baguelin M, Domenech de Celles M, Opatowski L
J Infect Dis
. 2021 Sep;
225(2):199-207.
PMID: 34514500
Background: Circulation of seasonal non-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) respiratory viruses with syndromic overlap during the coronavirus disease 2019 (COVID-19) pandemic may alter the quality of COVID-19 surveillance,...
10.
Kovacevic A, Latombe G, Chown S
Proc Biol Sci
. 2019 May;
286(1902):20190174.
PMID: 31039720
Critical thermal limits (CTLs) show much variation associated with the experimental rate of temperature change used in their estimation. Understanding the full range of variation in rate effects on CTLs...